16th Edition R&D Controlling and Performance Management

The Marcus Evans 16^th Edition R&D Controlling and Performance Management conference taking place in Amsterdam, Netherlands on 16-18 March, 2026 will tackle into some of the toughest challenges R&D controllers face today: securing funding for projects with uncertain outcomes, making the intangible value of innovation visible, and balancing transparency with the freedom researchers need to create. This conference will guide you through practical tools and real scenarios to transform uncertainty into actionable choices. You’ll learn how to build flexible budgets that withstand change, translate innovation into business value executives can back, and confidently sell R&D as a strategic growth driver. 

Attending this premier Marcus Evans conference will enable you to:
• Win the Case for Innovation – How to Sell R&D Value and Secure Funding
• Turn Strategy into a Compass for R&D Investment Decisions
• Shape Mindsets and Communication to Amplify R&D Controlling’s Impact
• Capture Innovation Value Beyond Traditional ROI
• Design KPIs That Actually Drive R&D Impact
• Future-Proof R&D Controlling with Advanced Technologies & ESG Tools

Best Practices and Case Studies from:
• Loïk-Maël Nys, Head of Finance for IBA Clinical, IBA, Belgium
• Marco Secreto, Head of R&D Portfolio & Project Management Governance, Iveco Group, Italy
• Ugur Savan, R&D Controller, MENARINI Group, USA
• Eyal Dayan, Head of Commercial Finance, Polpharma Group, Netherlands
• Arnaud Ducarouge, R&D Finance Global Process Lead, Sanofi, France
• Augusto Mattos Schaedler, Senior Director, Head of Space R&D, TERMA Group, Austria

Pharmiweb members are entitled to $200 discount! For more information please contact: Stefanos Ioannou, Digital Media and PR Executive at stefanosi@marcusevanscy.com or visit: https://tinyurl.com/mr3xjyvx